一名法官允许对 36 家制药商提起多州诉讼，指控 80 年至 2009 年间对 2016 种仿制药进行价格纵。 A judge lets a multistate lawsuit against 36 drugmakers proceed, alleging price-fixing on 80 generic drugs from 2009 to 2016.

康涅狄格州一名联邦法官允许对36名毒品制造者和管理人员提起多州反托拉斯诉讼,驳回了各州等待太久才提出的主张。 A federal judge in Connecticut has allowed a multistate antitrust lawsuit against 36 drugmakers and executives to proceed, rejecting claims that the states waited too long to file. 该案件指控包括Pfizer、Perrigo和Sandoz在内的公司在2009年至2016年期间密谋确定价格并限制80种非专利药品(主要是皮肤病药品)的竞争。 The case accuses companies including Pfizer, Perrigo, and Sandoz of conspiring to fix prices and limit competition for about 80 generic drugs, mainly for skin conditions, between 2009 and 2016. 法官发现有证据表明,被告试图通过无竞争力的投标和虚假费用索赔来掩盖串通。 The judge found evidence that defendants tried to hide collusion through uncompetitive bids and false cost claims. 该诉讼案由康涅狄格州牵头,涉及45个州和地区, 命名药物如Differin、Lotrimin AF和Ritalin。 The lawsuit, led by Connecticut and involving 45 states and territories, names drugs like Differin, Lotrimin AF, and Ritalin. 康涅狄格等案件。 The case, Connecticut et al. Sandoz Inc.等人,在法官作出130页的裁决后,将向前迈进。 v. Sandoz Inc. et al., will move forward after the judge’s 130-page decision.